Clin Exp Otorhinolaryngol.  2021 Feb;14(1):3-4. 10.21053/ceo.2021.00017.

The Use of MicroRNAs for the Early Diagnosis of Dementia in Patients Affected by Hearing Loss

• Yeo CD
• Park MK

• KMID: 2512872
• DOI: http://doi.org/10.21053/ceo.2021.00017

Reference

1. Larsson SC, Markus HS. Does treating vascular risk factors prevent dementia and alzheimer’s disease? A systematic review and meta-analysis. J Alzheimers Dis. 2018; 64(2):657–68.

2. World Health Organization. Addressing the rising prevalence of hearing loss [Internet]. Geneva: World Health Organization;2018 [cited 2021 Jan 20]. Available from: http://apps.who.int/iris/bitstream/handle/10665/260336/9789241550260-eng.pdf;jsessionid=420589F88F058B91C3A8B93AF67587C2?sequence=1.

3. Deal JA, Betz J, Yaffe K, Harris T, Purchase-Helzner E, Satterfield S, et al. Hearing impairment and incident dementia and cognitive decline in older adults: the health ABC study. J Gerontol A Biol Sci Med Sci. 2017; May. 72(5):703–9.

4. Wei CW, Luo T, Zou SS, Wu AS. Research progress on the roles of microRNAs in governing synaptic plasticity, learning and memory. Life Sci. 2017; Nov. 188:118–22.

5. Mun SK, Chae H, Piao XY, Lee HJ, Kim YK, Oh SH, et al. MicroRNAs related to cognitive impairment after hearing loss. Clin Exp Otorhinolaryngol. 2021; Feb. 14(1):76–81.